Adage Capital Partners
GRNA

Adage Capital Partners’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Adage Capital Partners’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-531,778
Closed -$5.26M – 1126
2021
Q3 		$5.26M Sell
531,778
-1,318,222
-71% -$12.9M 0.01% 827
2021
Q2 		$18.1M Hold
1,850,000
– – 0.04% 504
2021
Q1 		$17.9M Buy
+1,850,000
New +$18.2M 0.04% 497

Other funds holding GRNA

HCM
Highbridge Capital Management New York $1.58B AUM 31.19% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $5.03M AUM 3.16% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.36B AUM 24.94% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return